Aldosterone Bibliography of free accessible medical and biological reviews

Free Review Articles on Aldosterone Metatextbook

Freie Reviews über Aldosteron Look here for Journal Homepages

Aldosterone

Kidney (Chronic renal failure)

Endothelial dysfunction

RAAS (Renin angiotensin system)

Diastolic dysfunction

Kidney (Mesangial cell)

Receptor (Mineralcorticoid)

SGK1

Ciclosporin

Nr.	Year OPEN	Title	rate good	rate bad	no link	Citation
1	1968	Primary aldosteronism: review of 12 cases and present diagnostic criteria.	+	-	nl	South Med J 61(3):303-6 (1968) McCoy RM
2	2008	Aldosterone-to-renin ratio as a screening test for primary aldosteronism--the Dutch ARRAT Study.	+	-	nl	Neth J Med 66(5):220-8 (2008) Jansen PM
3	2009	The diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn Registry.	+	-	nl	Dtsch Arztebl Int 106(18):305-11 (2009) Schirpenbach C
4	2004	Aldosterone blockade in cardiovascular disease.	+	-	nl	Heart 90(10):1229-34 (2004) Struthers AD
5	2001	Aldosterone-induced vasculopathy: a new reversible cause of cardiac death.	+	-	nl	J Renin Angiotensin Aldosterone Syst 2(4):211-4 (2001)
6	2001	Diagnosis and management of primary aldosteronism.	+	-	nl	J Renin Angiotensin Aldosterone Syst 2(3):156-69 (2001)
7	1998	The use of locally delivered chlorhexidine in the treatment of periodontitis. Clinical results.	+	-	nl	J Clin Periodontol 25(11 Pt 2):953-8; discussion 978-9 (1998)
8	2009	Mineralocorticoid receptor blockers and chronic kidney disease.	+	-	nl	Clin J Am Soc Nephrol 4(10):1685-91 (2009) Jain G
9	2009	Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.	+	-	nl	Clin J Am Soc Nephrol 4(3):542-51 (2009) Navaneethan SD
10	2006	Aldosterone antagonism in chronic kidney disease.	+	-	nl	Clin J Am Soc Nephrol 1(4):668-77 (2006) Ponda MP
11	2010	Aldosterone: role in edematous disorders, hypertension, chronic renal failure, and metabolic syndrome.	+	-	nl	Clin J Am Soc Nephrol 5(6):1132-40 (2010) Schrier RW
12	2004	Control of aldosterone secretion: a model for convergence in cellular signaling pathways.	+	-	nl	Physiol Rev 84(2):489-539 (2004) Spat A
13	2008	A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function.	+	-	nl	Endocr Rev 29(2):133-54 (2008) Connell JM
14	2005	The nongenomic actions of aldosterone.	+	-	nl	Endocr Rev 26(3):313-21 (2005) Funder JW
15	2001	Nontraditional aspects of aldosterone physiology.	+	-	nl	Am J Physiol Endocrinol Metab 281(6):E1122-7 (2001)
16	1955	Aldosterone: a review.	+	-	nl	Can Med Assoc J 73(3):221-3 (1955)
17	2004	Aldosterone and anti-aldosterone effects in cardiovascular diseases and diabetic nephropathy.	+	-	nl	Diabetes Metab 30(4):311-8 (2004) Ambroisine ML
18	2007	Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication?	+	-	nl	Endocr J 54(4):487-95 (2007) Nishikawa T
19	2003	Minireview: primary aldosteronism--changing concepts in diagnosis and treatment.	+	-	nl	Endocrinology 144(6):2208-13 (2003) Young WF Jr
20	2007	Nongenomic actions of aldosterone on the renal tubule.	+	-	nl	Hypertension 49(4):728-39 (2007) Good DW
21	2006	Effects of aldosterone on the vasculature.	+	-	nl	Hypertension 47(3):312-8 (2006) Schiffrin EL
22	2004	The many targets of aldosterone.	+	-	nl	Hypertension 43(5):938-40 (2004) Schiffrin EL
23	2008	Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.	+	-	nl	J Clin Endocrinol Metab 93(9):3266-81 (2008) Funder JW
24	2008	A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III.	+	-	nl	J Clin Endocrinol Metab 93(8):2972-4 (2008) Mulatero P
25	2005	The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling.	+	-	nl	J Clin Endocrinol Metab 90(1):72-8 (2005) Tiu SC
26	2003	Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling.	+	-	nl	J Clin Endocrinol Metab 88(8):3637-44 (2003) Espiner EA
27	2003	Aldosterone: direct effects on and production by the heart.	+	-	nl	J Clin Endocrinol Metab 88(6):2376-83 (2003) White PC
28	2005	The new biology of aldosterone.	+	-	nl	J Endocrinol 186(1):1-20 (2005) Connell JM
29	2008	Primary aldosteronism: part II: subtype differentiation and treatment.	+	-	nl	J Nephrol 21(4):455-62 (2008) Rossi GP
30	2008	Primary aldosteronism - part I: prevalence, screening, and selection of cases for adrenal vein sampling.	+	-	nl	J Nephrol 21(4):447-54 (2008) Rossi GP
31	2001	Hyperaldosteronism: recent concepts, diagnosis, and management.	+	-	nl	Postgrad Med J 77(912):639-44 (2001)
32	2004	Mechanisms of hypertension: the expanding role of aldosterone.	+	-	nl	J Am Soc Nephrol 15(8):1993-2001 (2004) Freel EM
33	1992	The cellular action of aldosterone in target epithelia.	+	-	nl	Kidney Int 42(2):250-64 (1992)
34	2000	Familial hyperaldosteronism.	+	-	nl	Braz J Med Biol Res 33(10):1149-55 (2000)
35	2010	Roles of bone morphogenetic protein-6 in aldosterone regulation by adrenocortical cells.	+	-	nl	Acta Med Okayama 64(4):213-8 (2010)
36	2002	Aldosterone.	+	-	nl	Adv Physiol Educ 26(1-4):8-20 (2002)
37	2008	Effects of aldosterone on the heart: beyond systemic hemodynamics?	+	-	nl	Hypertension 52(3):462-4 (2008)
38	2008	Aldosterone and vascular inflammation.	+	-	nl	Hypertension 51(2):161-7 (2008)
39	2005	Aldosterone promotes endothelial dysfunction via prostacyclin independent of hypertension.	+	-	nl	Hypertension 46(1):29-30 (2005) Johnson FK
40	2004	Review of aldosterone- and angiotensin II-induced target organ damage and prevention.	+	-	nl	Cardiovasc Res 61(4):663-70 (2004)
41	2005	Editorial: aldosterone, normotension, and diastolic dysfunction.	+	-	nl	J Clin Endocrinol Metab 90(9):5500-1 (2005) Funder JW
42	2007	Aldosterone as a cardiovascular risk hormone.	+	-	nl	Endocr J 54(3):359-70 (2007)
43	2006	Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade.	+	-	nl	J Pharmacol Sci 100(1):9-16 (2006)
44	2011	Pathophysiological roles of aldosterone and mineralocorticoid receptor in the kidney.	+	-	nl	J Pharmacol Sci 115(1):1-7 (2011)
45	2010	New approaches to blockade of the renin-angiotensin-aldosterone system: mineralocorticoid-receptor blockers exert antihypertensive and renoprotective effects independently of the renin-angiotensin system.	+	-	nl	J Pharmacol Sci 113(4):310-4 (2010)
46	2008	Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury.	+	-	nl	J Pharmacol Sci 108(4):399-405 (2008)
47	2009	Drug discovery for overcoming chronic kidney disease (CKD): pharmacological effects of mineralocorticoid-receptor blockers.	+	-	nl	J Pharmacol Sci 109(1):1-6 (2009)
48	2005	Aldosterone in heart and kidney diseases.	+	-	nl	Hellenic J Cardiol 46(6):408-19 (2005)
49	2002	New ideas about aldosterone signaling in epithelia.	+	-	nl	Am J Physiol Renal Physiol 282(4):F559-76 (2002)
50	2007	New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone.	+	-	nl	Am J Physiol Renal Physiol 293(1):F2-9 (2007)
51	2009	Aldosterone in the brain.	+	-	nl	Am J Physiol Renal Physiol 297(3):F559-76 (2009)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.